Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT00002878 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

NETWORK

Sponsor class

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

DRUG: dexamethasone
DRUG: doxorubicin hydrochloride
DRUG: valspodar
DRUG: vincristine sulfate

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]